TEVA PHARMACEUTICAL INDUSTRIES LIMITED Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests of $38.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-03.
Financial Statements › Shareholders' Equity › Noncontrolling Interest Items
us-gaap:MinorityInterestDecreaseFromRedemptions · last filed 2026-02-03
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED noncontrolling interest, decrease from redemptions or purchase of interests for the quarter ending 2025-12-31 was $0.00.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED noncontrolling interest, decrease from redemptions or purchase of interests for the quarter ending 2025-09-30 was $0.00.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED noncontrolling interest, decrease from redemptions or purchase of interests for the quarter ending 2025-06-30 was $0.00.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED noncontrolling interest, decrease from redemptions or purchase of interests for the quarter ending 2025-03-31 was $38.00M, a 40.63% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED noncontrolling interest, decrease from redemptions or purchase of interests for fiscal 2025 was $38.00M, a 40.63% decline from fiscal 2024.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED noncontrolling interest, decrease from redemptions or purchase of interests for fiscal 2024 was $64.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED noncontrolling interest, decrease from redemptions or purchase of interests for fiscal 2016 was $1.68B.
| Period end | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 3 month | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 6 month | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 9 month | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $0.00 derived: sum of 2 quarters · filed 2026-02-03 | $0.00 derived: sum of 3 quarters · filed 2026-02-03 | $38.00M 10-K · filed 2026-02-03 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $38.00M 10-Q · filed 2025-11-05 | $38.00M derived: sum of 4 quarters · filed 2026-02-03 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $38.00M 10-Q · filed 2025-07-30 | $38.00M derived: sum of 3 quarters · filed 2026-02-03 | $38.00M derived: sum of 4 quarters · filed 2026-02-03 |
| 2025-03-31 | $38.00M 10-Q · filed 2025-11-05 | $38.00M derived: sum of 2 quarters · filed 2026-02-03 | $38.00M derived: sum of 3 quarters · filed 2026-02-03 | $38.00M derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $0.00 derived: sum of 2 quarters · filed 2026-02-03 | $0.00 derived: sum of 3 quarters · filed 2026-02-03 | $64.00M 10-K · filed 2026-02-03 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $64.00M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $64.00M 10-Q · filed 2025-07-30 | ||
| 2024-03-31 | $64.00M 10-Q · filed 2025-05-07 | |||
| 2016-12-31 | $1.68B 10-K · filed 2018-02-12 | |||
| 2015-12-31 | $103.00M 20-F · filed 2017-02-15 | |||
| 2014-12-31 | -$14.00M 20-F · filed 2016-02-11 | |||
| 2013-12-31 | -$12.00M 20-F · filed 2016-02-11 | |||
| 2011-12-31 | -$15.00M 20-F · filed 2014-02-10 | |||
| 2009-12-31 | -$26.00M 20-F · filed 2012-02-17 |